89Zr-CR011

N/A

Report date: 2025/01/26 17:02:24
NME

Base Information

Drug Name89Zr-CR011
Drug Alias Name89Zr-CR011 (Celldex Therapeutics Inc/Washington University in St Louis)[89Zr]ZrDFO-CR011
ClassificationRadiation-emitting productsSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCelldex Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesWashington UniversityCelldex Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A